Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial
| Image |  |
|---|---|
| Description | scientific article published on 15 January 2018 |
| Author/s |
author: Sandra Garcet Yeriel D Estrada Patricia M Gilleaudeau Mary Sullivan-Whalen Saakshi Khattri Danielle Baum Shelbi Jim On Emma Guttman-Yassky Judilyn Fuentes-Duculan Patrick M Brunner James G. Krueger Kunal Malik Claudia Traidl-Hoffmann Mark G. Lebwohl |
| Publication date | January 15, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |